Pro-Dex (PDEX) News Today $64.89 -2.03 (-3.03%) Closing price 04/25/2025 04:00 PM EasternExtended Trading$65.00 +0.11 (+0.17%) As of 04/25/2025 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Russell Investments Group Ltd. Buys Shares of 6,999 Pro-Dex, Inc. (NASDAQ:PDEX)Russell Investments Group Ltd. purchased a new stake in shares of Pro-Dex, Inc. (NASDAQ:PDEX - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor purchased 6,999 shares of the medical instruments supplier's stock, valued at apApril 27 at 3:26 AM | marketbeat.comPro-Dex (PDEX) Expected to Announce Earnings on ThursdayPro-Dex (NASDAQ:PDEX) will be releasing its Q3 2025 earnings before the market opens on Thursday, May 1. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-1-pro-dex-inc-stock/)April 26 at 3:10 AM | marketbeat.comPro-Dex, Inc. (NASDAQ:PDEX) Sees Significant Increase in Short InterestPro-Dex, Inc. (NASDAQ:PDEX - Get Free Report) saw a significant growth in short interest in March. As of March 31st, there was short interest totalling 62,200 shares, a growth of 38.2% from the March 15th total of 45,000 shares. Based on an average daily volume of 35,700 shares, the days-to-cover ratio is currently 1.7 days. Approximately 3.0% of the shares of the stock are short sold.April 20, 2025 | marketbeat.comEAM Investors LLC Buys New Stake in Pro-Dex, Inc. (NASDAQ:PDEX)EAM Investors LLC purchased a new position in Pro-Dex, Inc. (NASDAQ:PDEX - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 22,399 shares of the medical instruments supplier's stock, valApril 19, 2025 | marketbeat.comLSV Asset Management Sells 5,181 Shares of Pro-Dex, Inc. (NASDAQ:PDEX)LSV Asset Management cut its holdings in Pro-Dex, Inc. (NASDAQ:PDEX - Free Report) by 22.7% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 17,601 shares of the medical instruments supplier's stock after selling 5,181 shares during the quarter. LSV Asset ManApril 17, 2025 | marketbeat.comTrexquant Investment LP Buys New Stake in Pro-Dex, Inc. (NASDAQ:PDEX)Trexquant Investment LP bought a new position in shares of Pro-Dex, Inc. (NASDAQ:PDEX - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund bought 5,387 shares of the medical instruments supplier's stock, valued at approximately $25April 15, 2025 | marketbeat.com5,448 Shares in Pro-Dex, Inc. (NASDAQ:PDEX) Acquired by Arrowstreet Capital Limited PartnershipArrowstreet Capital Limited Partnership bought a new position in Pro-Dex, Inc. (NASDAQ:PDEX - Free Report) in the 4th quarter, according to its most recent filing with the SEC. The institutional investor bought 5,448 shares of the medical instruments supplier's stock, valued at approximately $255,April 15, 2025 | marketbeat.comAmerican Century Companies Inc. Acquires New Position in Pro-Dex, Inc. (NASDAQ:PDEX)American Century Companies Inc. bought a new position in Pro-Dex, Inc. (NASDAQ:PDEX - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 11,946 shares of the medical instruments supplApril 14, 2025 | marketbeat.com21,277 Shares in Pro-Dex, Inc. (NASDAQ:PDEX) Acquired by O Shaughnessy Asset Management LLCO Shaughnessy Asset Management LLC acquired a new stake in Pro-Dex, Inc. (NASDAQ:PDEX - Free Report) during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 21,277 shares of the medical instruments supplier's stock, valued at approximateApril 9, 2025 | marketbeat.comIntegrated Quantitative Investments LLC Acquires New Shares in Pro-Dex, Inc. (NASDAQ:PDEX)Integrated Quantitative Investments LLC bought a new position in Pro-Dex, Inc. (NASDAQ:PDEX - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 5,432 shares of the medical instruments supplier's stock, valued at approximateApril 8, 2025 | marketbeat.comInsider Selling: Pro-Dex, Inc. (NASDAQ:PDEX) Director Sells 842 Shares of StockPro-Dex, Inc. (NASDAQ:PDEX - Get Free Report) Director Raymond E. Cabillot sold 842 shares of the stock in a transaction that occurred on Friday, March 28th. The shares were sold at an average price of $50.00, for a total value of $42,100.00. Following the transaction, the director now owns 278,945 shares of the company's stock, valued at $13,947,250. This represents a 0.30 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link.April 2, 2025 | marketbeat.comPro-Dex, Inc. (NASDAQ:PDEX) Director Raymond E. Cabillot Sells 842 SharesApril 2, 2025 | insidertrades.comPro-Dex, Inc. (NASDAQ:PDEX) Director Sells $41,800.00 in StockPro-Dex, Inc. (NASDAQ:PDEX - Get Free Report) Director Raymond E. Cabillot sold 836 shares of the stock in a transaction on Monday, March 31st. The stock was sold at an average price of $50.00, for a total value of $41,800.00. Following the completion of the sale, the director now owns 278,109 shares in the company, valued at approximately $13,905,450. The trade was a 0.30 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.April 1, 2025 | marketbeat.comPro-Dex, Inc. (NASDAQ:PDEX) Director Raymond E. Cabillot Sells 836 SharesApril 1, 2025 | insidertrades.comPro-Dex, Inc. (NASDAQ:PDEX) Director Raymond E. Cabillot Sells 3,096 SharesPro-Dex, Inc. (NASDAQ:PDEX - Get Free Report) Director Raymond E. Cabillot sold 3,096 shares of the business's stock in a transaction dated Wednesday, March 26th. The shares were sold at an average price of $50.13, for a total transaction of $155,202.48. Following the completion of the transaction, the director now directly owns 279,787 shares of the company's stock, valued at $14,025,722.31. The trade was a 1.09 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.March 28, 2025 | marketbeat.comShort Interest in Pro-Dex, Inc. (NASDAQ:PDEX) Rises By 166.3%Pro-Dex, Inc. (NASDAQ:PDEX - Get Free Report) saw a significant increase in short interest in March. As of March 15th, there was short interest totalling 45,000 shares, an increase of 166.3% from the February 28th total of 16,900 shares. Based on an average daily volume of 31,600 shares, the days-to-cover ratio is presently 1.4 days. Approximately 2.2% of the shares of the stock are short sold.March 28, 2025 | marketbeat.comInsider Selling: Pro-Dex, Inc. (NASDAQ:PDEX) Director Sells 3,096 Shares of StockMarch 28, 2025 | insidertrades.comPro-Dex, Inc. (NASDAQ:PDEX) Director Sells $139,200.00 in StockPro-Dex, Inc. (NASDAQ:PDEX - Get Free Report) Director Raymond E. Cabillot sold 2,784 shares of Pro-Dex stock in a transaction that occurred on Monday, March 24th. The shares were sold at an average price of $50.00, for a total transaction of $139,200.00. Following the completion of the sale, the director now owns 295,810 shares of the company's stock, valued at approximately $14,790,500. The trade was a 0.93 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link.March 26, 2025 | marketbeat.comPro-Dex, Inc. (NASDAQ:PDEX) Director Sells $50,000.00 in StockPro-Dex, Inc. (NASDAQ:PDEX - Get Free Report) Director Raymond E. Cabillot sold 1,000 shares of the business's stock in a transaction dated Wednesday, March 19th. The shares were sold at an average price of $50.00, for a total transaction of $50,000.00. Following the completion of the transaction, the director now owns 299,695 shares in the company, valued at approximately $14,984,750. The trade was a 0.33 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.March 22, 2025 | marketbeat.comPro-Dex, Inc. (NASDAQ:PDEX) Director Sells $257,550.00 in StockPro-Dex, Inc. (NASDAQ:PDEX - Get Free Report) Director Raymond E. Cabillot sold 5,151 shares of the stock in a transaction dated Friday, March 14th. The stock was sold at an average price of $50.00, for a total transaction of $257,550.00. Following the sale, the director now owns 300,695 shares of the company's stock, valued at approximately $15,034,750. This represents a 1.68 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website.March 18, 2025 | marketbeat.comPro-Dex, Inc. (NASDAQ:PDEX) Short Interest UpdatePro-Dex, Inc. (NASDAQ:PDEX - Get Free Report) was the target of a large decline in short interest in the month of February. As of February 28th, there was short interest totalling 16,900 shares, a decline of 21.8% from the February 13th total of 21,600 shares. Currently, 0.8% of the shares of the company are short sold. Based on an average trading volume of 30,900 shares, the days-to-cover ratio is currently 0.5 days.March 18, 2025 | marketbeat.comInsider Selling: Pro-Dex, Inc. (NASDAQ:PDEX) Director Sells 5,151 Shares of StockMarch 18, 2025 | insidertrades.comPro-Dex (NASDAQ:PDEX) Lowered to Hold Rating by StockNews.comStockNews.com downgraded Pro-Dex from a "buy" rating to a "hold" rating in a report on Wednesday.March 13, 2025 | marketbeat.comRaymond E. Cabillot Sells 7,674 Shares of Pro-Dex, Inc. (NASDAQ:PDEX) StockPro-Dex, Inc. (NASDAQ:PDEX - Get Free Report) Director Raymond E. Cabillot sold 7,674 shares of Pro-Dex stock in a transaction dated Monday, March 10th. The stock was sold at an average price of $45.00, for a total transaction of $345,330.00. Following the transaction, the director now owns 310,978 shares of the company's stock, valued at approximately $13,994,010. The trade was a 2.41 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link.March 12, 2025 | marketbeat.comWith 38% ownership in Pro-Dex, Inc. (NASDAQ:PDEX), hedge funds investors have a lot riding on the businessMarch 11, 2025 | finance.yahoo.comPro-Dex (NASDAQ:PDEX) Stock Crosses Above Two Hundred Day Moving Average - Here's WhyPro-Dex (NASDAQ:PDEX) Share Price Crosses Above Two Hundred Day Moving Average - Time to Sell?March 4, 2025 | marketbeat.comPro-Dex (NASDAQ:PDEX) Shares Pass Above 200 Day Moving Average - Time to Sell?Pro-Dex (NASDAQ:PDEX) Stock Price Crosses Above 200 Day Moving Average - What's Next?February 14, 2025 | marketbeat.comPro-Dex (PDEX) Projected to Post Earnings on ThursdayPro-Dex (NASDAQ:PDEX) will be releasing earnings before the market opens on Thursday, February 13, Financial Modeling Prep reports.February 6, 2025 | marketbeat.comInsider Selling: Pro-Dex, Inc. (NASDAQ:PDEX) Director Sells 1,100 Shares of StockFebruary 4, 2025 | insidertrades.comPro-Dex (NASDAQ:PDEX) Downgraded to "Buy" Rating by StockNews.comStockNews.com lowered shares of Pro-Dex from a "strong-buy" rating to a "buy" rating in a research note on Monday.February 3, 2025 | marketbeat.comRaymond E. Cabillot Sells 1,100 Shares of Pro-Dex, Inc. (NASDAQ:PDEX) StockPro-Dex, Inc. (NASDAQ:PDEX - Get Free Report) Director Raymond E. Cabillot sold 1,100 shares of Pro-Dex stock in a transaction dated Thursday, January 30th. The stock was sold at an average price of $45.01, for a total value of $49,511.00. Following the transaction, the director now directly owns 318,652 shares in the company, valued at approximately $14,342,526.52. The trade was a 0.34 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.February 3, 2025 | marketbeat.comPro-Dex (NASDAQ:PDEX) Issues Earnings Results, Beats Estimates By $0.23 EPSPro-Dex (NASDAQ:PDEX - Get Free Report) posted its quarterly earnings data on Thursday. The medical instruments supplier reported $0.61 earnings per share for the quarter, beating the consensus estimate of $0.38 by $0.23. Pro-Dex had a net margin of 9.17% and a return on equity of 16.74%.January 30, 2025 | marketbeat.comPro Dex director Cabillot sells shares worth $560,229January 28, 2025 | msn.comRaymond E. Cabillot Sells 5,381 Shares of Pro-Dex, Inc. (NASDAQ:PDEX) StockPro-Dex, Inc. (NASDAQ:PDEX - Get Free Report) Director Raymond E. Cabillot sold 5,381 shares of the firm's stock in a transaction dated Tuesday, January 28th. The stock was sold at an average price of $41.64, for a total value of $224,064.84. Following the sale, the director now directly owns 319,752 shares in the company, valued at $13,314,473.28. This trade represents a 1.66 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link.January 28, 2025 | marketbeat.comPro-Dex, Inc. (NASDAQ:PDEX) Director Sells $35,070.00 in StockJanuary 25, 2025 | insidertrades.comPro dex director Raymond Cabillot sells shares worth $94,577January 24, 2025 | msn.comPro-Dex, Inc. (NASDAQ:PDEX) Director Raymond E. Cabillot Sells 835 SharesPro-Dex, Inc. (NASDAQ:PDEX - Get Free Report) Director Raymond E. Cabillot sold 835 shares of the firm's stock in a transaction dated Thursday, January 23rd. The stock was sold at an average price of $42.00, for a total transaction of $35,070.00. Following the completion of the transaction, the director now owns 334,646 shares of the company's stock, valued at approximately $14,055,132. The trade was a 0.25 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.January 24, 2025 | marketbeat.comRaymond E. Cabillot Sells 6,931 Shares of Pro-Dex, Inc. (NASDAQ:PDEX) StockJanuary 23, 2025 | insidertrades.comPro Dex Inc director Raymond Cabillot sells $409,925 in stockJanuary 22, 2025 | msn.comInsider Selling: Pro-Dex, Inc. (NASDAQ:PDEX) Director Sells 6,931 Shares of StockPro-Dex, Inc. (NASDAQ:PDEX - Get Free Report) Director Raymond E. Cabillot sold 6,931 shares of the stock in a transaction on Tuesday, January 21st. The shares were sold at an average price of $45.22, for a total value of $313,419.82. Following the completion of the transaction, the director now owns 337,752 shares of the company's stock, valued at $15,273,145.44. The trade was a 2.01 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink.January 22, 2025 | marketbeat.com12,233 Shares in Pro-Dex, Inc. (NASDAQ:PDEX) Acquired by Ritholtz Wealth ManagementRitholtz Wealth Management bought a new position in Pro-Dex, Inc. (NASDAQ:PDEX - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 12,233 shares of the medical instruments supplier's stock, vJanuary 21, 2025 | marketbeat.comPro Dex director Raymond Cabillot sells shares worth $371,988January 17, 2025 | msn.comRaymond E. Cabillot Sells 6,820 Shares of Pro-Dex, Inc. (NASDAQ:PDEX) StockPro-Dex, Inc. (NASDAQ:PDEX - Get Free Report) Director Raymond E. Cabillot sold 6,820 shares of the business's stock in a transaction dated Friday, January 17th. The shares were sold at an average price of $44.86, for a total value of $305,945.20. Following the sale, the director now directly owns 344,683 shares of the company's stock, valued at approximately $15,462,479.38. This trade represents a 1.94 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link.January 17, 2025 | marketbeat.comRaymond E. Cabillot Sells 1,879 Shares of Pro-Dex, Inc. (NASDAQ:PDEX) StockJanuary 16, 2025 | insidertrades.comPro-Dex, Inc. (NASDAQ:PDEX) Director Raymond E. Cabillot Sells 1,200 SharesJanuary 15, 2025 | insidertrades.comPro-Dex, Inc. (NASDAQ:PDEX) Director Raymond E. Cabillot Sells 1,200 SharesPro-Dex, Inc. (NASDAQ:PDEX - Get Free Report) Director Raymond E. Cabillot sold 1,200 shares of Pro-Dex stock in a transaction dated Friday, January 10th. The shares were sold at an average price of $47.76, for a total value of $57,312.00. Following the transaction, the director now directly owns 359,646 shares of the company's stock, valued at $17,176,692.96. The trade was a 0.33 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.January 14, 2025 | marketbeat.comInsider Selling: Pro-Dex, Inc. (NASDAQ:PDEX) Director Sells 3,624 Shares of StockPro-Dex, Inc. (NASDAQ:PDEX - Get Free Report) Director Raymond E. Cabillot sold 3,624 shares of the firm's stock in a transaction on Monday, January 13th. The stock was sold at an average price of $46.66, for a total value of $169,095.84. Following the completion of the transaction, the director now owns 356,022 shares in the company, valued at approximately $16,611,986.52. This trade represents a 1.01 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.January 14, 2025 | marketbeat.comReturns On Capital At Pro-Dex (NASDAQ:PDEX) Have StalledJanuary 13, 2025 | uk.finance.yahoo.comPro-Dex (NASDAQ:PDEX) shareholders have earned a 22% CAGR over the last five yearsDecember 24, 2024 | uk.finance.yahoo.comStockNews.com Upgrades Pro-Dex (NASDAQ:PDEX) to Strong-BuyStockNews.com upgraded Pro-Dex from a "buy" rating to a "strong-buy" rating in a research report on Saturday.December 14, 2024 | marketbeat.com Get Pro-Dex News Delivered to You Automatically Sign up to receive the latest news and ratings for PDEX and its competitors with MarketBeat's FREE daily newsletter. Email Address PDEX Media Mentions By Week PDEX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PDEX News Sentiment▼0.800.86▲Average Medical News Sentiment PDEX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PDEX Articles This Week▼41▲PDEX Articles Average Week Get Pro-Dex News Delivered to You Automatically Sign up to receive the latest news and ratings for PDEX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies AXGN News Today IRMD News Today EMBC News Today BVS News Today RXST News Today SIBN News Today AVNS News Today BFLY News Today CBLL News Today KIDS News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PDEX) was last updated on 4/28/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredIt’s absolute chaos in Silicon Valley right now…If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk...Brownstone Research | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pro-Dex, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pro-Dex With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy PDEX Stock Free PDEX Stock Alerts